Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Target Discovery
Axion: Cardiac Activity Assay
In vitro models are a proven powerful strategy for studying disorders of the human heart.
Organ Modelling
Cellesce: Colorectal Cancer Organoid Lines
Cellesce’s technology enables the growth and expansion of Patient-Derived Organoids (PDOs)
Molecular Drug Design
Accuracy and Precision of Arrow Directionality in the Causaly Knowledge Graph
Causaly have developed an advanced machine-reading platform for semantic relationship extraction and comprehension
Target Discovery
Axion MEA Plates
When your research requires insightful, high-quality data from microelectrode arrays (MEAs), Axion BioSystems’ MEA plates provide the right balance of throughput, electrode count, and ease of use for your experiments.
Molecular Drug Design
AI and ML for Target Validation & Lead Optimization
Jackie Hunter, Board Director at BenevolentAI, shares details on her company's unique approach to target Identification and lead optimisation.
Target Discovery
Target Identification: Navigating the Intricate Environment of Human Biology
Balancing novelty and validity, the role of probability in target identification, and discussing the role of the genetic links to disease indications.
Organ Modelling
Multivascular Networks and Functional IntravascularTopologies within Biocompatible Hydrogels
Modeling multidimensional vascular networks is a notoriously difficult task, especially when considering the complex functions they perform within organ systems.
Chemical Biology
The Bioavailability of Oral PROTAC Molecules for ER+ Breast Cancer
Thomas Hayhow, Associate Principal Scientist at AstraZeneca presents his company’s efforts in delivering PROTACs orally.
Molecular Drug Design
Expanding the Use of AI in Healthcare Services
Recent developments in healthcare include the integration of AI chatbots in order to support primary care providers, offering improved patient care and efficiency in providing healthcare solutions.
Automation
Digitisation and Beyond: Understanding the Lab of the Future
Key opinion leaders from GSK and the University of Southampton discuss the steps needed to reach the lab of the future.